MétaCan
Menu
Back to cohort
Record W2952644236 · doi:10.1038/s41416-019-0492-8

Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

2019· article· en· W2952644236 on OpenAlexafffund
Frank Qian, Matti A. Rookus, Goska Leslie, Harvey A. Risch, Mark H. Greene, Cora M. Aalfs, Muriel A. Adank, Julian Adlard, Bjarni A. Agnarsson, Munaza Ahmed, Kristiina Aittomäki, Irene L. Andrulis, Norbert Arnold, Banu Arun, Margreet G.E.M. Ausems, Jacopo Azzollini, Daniel Barrowdale, Julian Barwell, Javier Benı́tez, Katarzyna Białkowska, Valérie Bonadona, Julika Borde, Åke Borg, Angela R. Bradbury, Joan Brunet, Saundra S. Buys, Trinidad Caldés, Maria A. Caligo, Ian Campbell, Jonathan Carter, Jocelyne Chiquette, Wendy K. Chung, Kathleen Claes, J. Margriet Collée, Marie‐Agnès Collonge‐Rame, Fergus J. Couch, Mary B. Daly, Capucine Delnatte, Orland Dı́ez, Susan M. Domchek, Cecilia M. Dorfling, Jacqueline Eason, Douglas F. Easton, Rosalind A. Eeles, Christoph Engel, D. Gareth Evans, Laurence Faivre, Lídia Feliubadaló, Lenka Foretová, Eitan Friedman, Debra Frost, Patricia A. Ganz, Judy E. Garber, Vanesa García‐Barberán, Andrea Gehrig, Gord Glendon, Andrew K. Godwin, E. Gómez, Ute Hamann, Jan Hauke, John L. Hopper, Peter J. Hulick, Evgeny N. Imyanitov, Claudine Isaacs, Louise Izatt, Anna Jakubowska, Ramūnas Janavičius, Esther M. John, Beth Y. Karlan, Carolien M. Kets, Yael Laitman, Conxi Lázaro, Dominique Leroux, Jenny Lester, Fabienne Lesueur, Jennifer T. Loud, Jan Lubiński, Alicja Łukomska, Lesley McGuffog, Noura Mebirouk, Hanne Meijers‐Heijboer, Alfons Meindl, Austin Miller, Marco Montagna, Thea M. Mooij, Emmanuelle Mouret‐Fourme, Katherine L. Nathanson, Bita Nehoray, Susan L. Neuhausen, Heli Nevanlinna, Finn Cilius Nielsen, Kenneth Offit, Edith Olah, Kai-Ren Ong, Jan C. Oosterwijk, Laura Ottini, Michael T. Parsons, Paolo Peterlongo, Georg Pfeiler, Nisha Pradhan, Paolo Radice, Susan J. Ramus, Johanna Rantala, Gad Rennert, Mark E. Robson, Gustavo C. Rodriguez, Ritu Salani, Maren T. Scheuner, Rita K. Schmutzler, Payal D. Shah, Lucy Side, Jacques Simard, Christian F. Singer, Doris Steinemann, Dominique Stoppa‐Lyonnet, Yen Y. Tan, Manuel R. Teixeira, Mary Beth Terry, Mads Thomassen, Marc Tischkowitz, Silvia Tognazzo, Amanda E. Toland, Nadine Tung, Christi J. van Asperen, Klaartje van Engelen, Elizabeth J. van Rensburg, Laurence Venat‐Bouvet, Jeroen Vierstraete, Gabriel Wagner, Lisa Walker, Jeffrey N. Weitzel, Drakoulis Yannoukakos, Antonis C. Antoniou, David E. Goldgar, Olufunmilayo I. Olopade, Georgia Chenevix‐Trench, Timothy R. Rebbeck, Dezheng Huo

Bibliographic record

VenueBritish Journal of Cancer · 2019
Typearticle
Languageen
FieldMedicine
TopicOvarian cancer diagnosis and treatment
Canadian institutionsMcGill UniversityUniversité LavalUniversity of TorontoCentre hospitalier universitaire de QuébecHôpital du Saint-SacrementLunenfeld-Tanenbaum Research InstituteMount Sinai Hospital
FundersJonsson Comprehensive Cancer CenterNational Center for Advancing Translational SciencesEuropean Regional Development FundCanadian Institutes of Health Researchlékařská fakulta Univerzity KarlovyManchester Biomedical Research CentreUniversity of California, San FranciscoNational Institutes of HealthKerry Group Kuok FoundationFreistaat SachsenCentro de Investigación Biomédica en Red de CáncerFox Chase Cancer CenterMinistero dello Sviluppo EconomicoMedical Research CouncilUppsala UniversitetNational Institute of General Medical SciencesInstitut National Du CancerDeutsche KrebshilfeSahlgrenska UniversitetssjukhusetAssociazione Italiana per la Ricerca sul CancroOvarian Cancer Research FundMinisterio de Economía y CompetitividadLandspítali HáskólasjúkrahúsLinköpings UniversitetHungarian Scientific Research FundNederlandse Organisatie voor Wetenschappelijk OnderzoekMinistero della SaluteGeneralitat de CatalunyaRussian Foundation for Basic ResearchCancer Association of South AfricaMinisterstvo Školství, Mládeže a TělovýchovyNational Breast Cancer FoundationEuropean CommissionNational Institute for Health and Care ResearchKWF KankerbestrijdingCancer Research UKGovernment of CanadaNational Cancer InstituteLiga Portuguesa Contra o CancroHospital de Câncer de BarretosNRG OncologyMemorial Sloan-Kettering Cancer CenterFondation du cancer du sein du QuébecIsrael Cancer AssociationInstitut Català de la SalutUniversity of PennsylvaniaFundación Mutua MadrileñaMinistère du Développement Économique, de l’Innovation et de l’ExportationGenome CanadaBreast Cancer Research FoundationMcGill UniversityUniverzita Karlova v PrazeUnicancerClalit Health ServicesDeutsches KrebsforschungszentrumAmerican Cancer SocietyFonds Wetenschappelijk OnderzoekCancer Center, University of KansasCancerfondenMinistério da Ciência, Tecnologia e InovaçãoDr. Ralph and Marian Falk Medical Research TrustKansas Bioscience AuthorityBeth Israel Deaconess Medical CenterAlpha Omega Alpha Honor Medical SocietyGeorgetown UniversitySusan G. Komen for the CureInstituto de Salud Carlos IIIOhio State UniversityCancer AustraliaNational Health and Medical Research CouncilJewish General HospitalFundación CellexFisher Center for Alzheimer's Research FoundationIstituto Oncologico VenetoUmeå UniversitetRoyal Marsden NHS Foundation TrustEuropean Social FundUniversity of ChicagoLietuvos Mokslo Taryba
KeywordsOvarian cancerBody mass indexOncologyMedicineMendelian inheritanceMutationInternal medicineCancerGeneticsBiologyGynecologyGene

Abstract

fetched live from OpenAlex

Height and body mass index (BMI) are associated with higher ovarian cancer risk in the general population, but whether such associations exist among BRCA1/2 mutation carriers is unknown. We applied a Mendelian randomisation approach to examine height/BMI with ovarian cancer risk using the Consortium of Investigators for the Modifiers of BRCA1/2 (CIMBA) data set, comprising 14,676 BRCA1 and 7912 BRCA2 mutation carriers, with 2923 ovarian cancer cases. We created a height genetic score (height-GS) using 586 height-associated variants and a BMI genetic score (BMI-GS) using 93 BMI-associated variants. Associations were assessed using weighted Cox models. Observed height was not associated with ovarian cancer risk (hazard ratio [HR]: 1.07 per 10-cm increase in height, 95% confidence interval [CI]: 0.94–1.23). Height-GS showed similar results (HR = 1.02, 95% CI: 0.85–1.23). Higher BMI was significantly associated with increased risk in premenopausal women with HR = 1.25 (95% CI: 1.06–1.48) and HR = 1.59 (95% CI: 1.08–2.33) per 5-kg/m 2 increase in observed and genetically determined BMI, respectively. No association was found for postmenopausal women. Interaction between menopausal status and BMI was significant ( P interaction < 0.05). Our observation of a positive association between BMI and ovarian cancer risk in premenopausal BRCA1/2 mutation carriers is consistent with findings in the general population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.080
Threshold uncertainty score0.981

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.277
Teacher spread0.270 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations23
Published2019
Admission routes2
Has abstractyes

Explore more

Same venueBritish Journal of CancerSame topicOvarian cancer diagnosis and treatmentFrench-language works237,207